The Fourth Universal Definition of Myocardial Infarction recommends high-sensitivity troponin assays for routine clinical use. Compared to standard (guideline-acceptable) cardiac troponin assays, high-sensitivity assays offer improved sensitivity and unparalleled precision at the low end of the measuring range. With the availability of high-sensitivity troponin I assays in the U.S., more laboratories have the ability to implement high-sensitivity troponin I.
Join Dr. Allan Jaffe to learn about the latest recommendations and communication needed with your key clinical partners when transitioning to a high-sensitivity troponin assay.
After this webinar, participants will:
1. Understand the latest recommendations from the Fourth Universal Definition of Myocardial Infarction
2. Learn how to discriminate myocardial infarction from myocardial injury when troponin values are elevated
3. Know what common questions to expect from your clinical stakeholders and how to proactively collaborate
Allan S. Jaffe, M.D., is a Consultant and Chair of the Division of Clinical Core Laboratory Services at Mayo Clinic in Rochester, Minnesota, with a joint appointment in the Division of Cardiovascular Diseases. He holds the academic rank of Professor of Laboratory Medicine and Pathology and also Professor of Medicine.
Is your lab ready for high-sensitivity troponin I?
High-Sensitivity Troponin I is the latest addition to Siemens Healthineers’ comprehensive cardiac menu to assist clinicians with the diagnosis and treatment of chest pain patients. Designed to aid in diagnosing acute myocardial infarctions (AMI) through the quantitative measurement of cardiac troponin I in serum or plasma, high-sensitivity troponin plays a critical role in the timely diagnosis of AMI, or heart attacks.
High-sensitivity Troponin I is now available on the Atellica® IM Analyzer, ADVIA Centaur® Immunoassay System, Dimension® EXL™ and Dimension Vista® Integrated Systems.